• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medical Resources completes debt accord

Article

Imaging services provider Medical Resources of Hackensack, NJ, has completed an agreement with a group of corporate bond holders that restructures the terms of senior notes held by the investors. Medical Resources had fallen into technical default on the

Imaging services provider Medical Resources of Hackensack, NJ, has completed an agreement with a group of corporate bond holders that restructures the terms of senior notes held by the investors. Medical Resources had fallen into technical default on the notes because of covenants that required it to maintain a certain level of net income (SCAN 9/2/98).

Under the restructured deal, the bond holders agreed to waive the company’s defaults and modify the terms of the notes to relax the net income provisions. Medical Resources has agreed to prepay $2 million in principal out of a total of $78 million, issue stock purchase warrants to the note holders, and pay a higher interest rate on the notes.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.